PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jroyalcgpracBJGP at RCGPBJGP at PubMed CentralJ R Coll Gen Pract at PubMed CentralRCGP homepage
 
J R Coll Gen Pract. 1970 November; 20(100): 269–277.
PMCID: PMC2237384

Essential hypertension and its treatment by the family physician. A study of sixty-one cases.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bath J, Pickering D, Turner R. Clinical experience with bethanidine in treatment of hypertension. Br Med J. 1967 Dec 2;4(5578):519–521. [PMC free article] [PubMed]
  • BEIN HJ. Zur Pharmakologie des Reserpin, eines neuen Alkaloids aus Rauwolfia serpentina Benth. Experientia. 1953 Mar 15;9(3):107–110. [PubMed]
  • FREIS ED, ARI R. Clinical and experimental effects of reserpine in patients with essential hypertension. Ann N Y Acad Sci. 1954 Apr 30;59(1):45–53. [PubMed]
  • GRIEBLE HG, JOHNSTON LC. Treatment of arterial hypertensive disease with diuretics. I. Effects on blood pressure of bendroflumethiazide, potassium chloride, and spironolactone. Arch Intern Med. 1962 Jul;110:26–33. [PubMed]
  • HAMILTON M, THOMPSON EM, WISNIEWSKI TK. THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION. Lancet. 1964 Feb 1;1(7327):235–238. [PubMed]
  • HARRIS R. Clinical use of reserpine (serpasil) in geriatrics. Ann N Y Acad Sci. 1954 Apr 30;59(1):95–106. [PubMed]
  • KOBINGER W, KATIC U. [The pharmacological properties of benzylhydroflumethiazide, a new orally effective diuretic]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;238:435–453. [PubMed]
  • LEISHMAN AW. Hypertension: treated and untreated; a study of 400 cases. Br Med J. 1959 May 30;1(5134):1361–1368. [PMC free article] [PubMed]
  • McQUEEN EG, DOYLE AE, SMIRK FH. The circulatory effects of reserpine. Circulation. 1955 Feb;11(2):161–169. [PubMed]
  • MARSHALL J. A TRIAL OF LONG-TERM HYPOTENSIVE THERAPY IN CEREBROVASCULAR DISEASE. Lancet. 1964 Jan 4;1(7323):10–12. [PubMed]
  • PLATT R. THE NATURAL HISTORY AND EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION. Practitioner. 1964 Jul;193:5–13. [PubMed]
  • PLUMMER AJ, EARL A, SCHNEIDER JA, TRAPOLD J, BARRETT W. Pharmacology of Rauwolfia alkaloids, including reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):8–21. [PubMed]
  • Porter AM. Drug defaulting in a general practice. Br Med J. 1969 Jan 25;1(5638):218–222. [PMC free article] [PubMed]
  • Prichard BN. Hypotensive drugs. Practitioner. 1968 Jan;200(195):30–38. [PubMed]
  • RICHARDSON DW, HONOUR AJ, FENTON GW, STOTT FH, PICKERING GW. VARIATION IN ARTERIAL PRESSURE THROUGHOUT THE DAY AND NIGHT. Clin Sci. 1964 Jun;26:445–460. [PubMed]
  • SCHLITTLER E, MACPHILLAMY HB, DORFMAN L, FURLENMEIER A, HUEBNER CF, LUCAS R, MUELLER JM, SCHWYZER R, ST. ANDRE AF. Chemistry of Rauwolfia alkaloids, including reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):1–7. [PubMed]
  • TAPIA FA, DUSTAN HP, SCHNECKLOTH RA, CORCORAN AC, PAGE IH. Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during administration of a saluretic agent (chlorothiazide). Lancet. 1957 Oct 26;273(7000):831–833. [PubMed]
  • VAKIL RJ. A clinical trial of Rauwolfia serpentina in essential hypertension. Br Heart J. 1949 Oct;11(4):350–355. [PMC free article] [PubMed]
  • WILKINS RW. Clinical usage of Rauwolfia alkaloids, including reserpine (serpasil). Ann N Y Acad Sci. 1954 Apr 30;59(1):36–44. [PubMed]
  • WINSOR T. Human pharmacology of reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):61–81. [PubMed]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners